• Home
  • Our Services
  • Our Research
    • Our Vision>
      • Mission Statement
      • A Brief Overview
      • Historic Overview
    • What We've Accomplished
    • Works In Progress
    • Future Goals
    • Bibliography
  • Meet the Team
    • Contact Us
    • Cognistrata Blog
  • Donate

FUTURE GOALS

Development of targeted treatments for Alzheimer’s and Parkinson’s diseases that restore the integrity of the brain network and prevent the cognitive decline.

Picture
The identification of the signaling components that break down in the early stages of Alzheimer's and Parkinson's disease will allow us to develop tailored treatments for these conditions. Most of the current research on AD and PD is focused on reversing the pathological changes in the late stages of these conditions, when significant neuronal loss had occurred. In contrast, the treatments we strive to develop are focused on restoring the normal signaling and integrity of the brain network at early stages of these conditions when only the sense of smell is affected and cognition and memories are still intact. 


        


Powered by Create your own unique website with customizable templates.